![Noah Goodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noah Goodman
Corporate Officer/Principal bei
KYMERA THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.07.2026
Profil
Mr. Noah Goodman is a Chief Business Officer at Kymera Therapeutics, Inc. Mr. Goodman was previously employed as a President & Chief Business Officer by Chroma Medicine, Inc., an Executive Director & Head-Business Development by Cadent Therapeutics, Inc., and a Head-Business Development by Spark Therapeutics, Inc. He received his undergraduate degree from the University of Michigan and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2026 | 47.179 ( 0,06 % ) | 5 Mio $ | 31.07.2026 |
Aktive Positionen von Noah Goodman
| Unternehmen | Position | Beginn |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 09.04.2025 |
Ehemalige bekannte Positionen von Noah Goodman
| Unternehmen | Position | Ende |
|---|---|---|
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Präsident | 01.04.2025 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Direktor/Vorstandsmitglied | 01.03.2021 |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Noah Goodman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
